Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01434342 · ClinicalTrials.gov registry record · Early Phase 1
Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients
A Early Phase 1 study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 146
- Enrollment target
NCT01434342: Completed Early Phase 1 study, sponsored by Wake Forest University Health Sciences.
NCT01434342 is a Early Phase 1 study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 146 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (175% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01434342, a Early Phase 1 study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 146 participants
- Enrollment target
Study Summary
RATIONALE: Continued smoking after a cancer diagnosis has important health consequences beyond the risks associated with smoking in the general population. Smoking reduces the efficacy of cancer treatments including surgery, radiation and chemotherapy. Despite the negative consequences, it is estimated that between 15-75% of patients with cancer continue to smoke after their cancer diagnosis. Lung, breast, prostate, colorectal, bladder, head \& neck, and cervical cancer patients were chosen because there is evidence of potential clinical benefit associated with quitting smoking in all of these populations and they represent a mix of both smoking and non-smoking related cancers.
Primary Outcome
The primary feasibility measures are retention and adherence. This outcome, retention, is the percentage of patient who remain in the study for 24 weeks.
Interventions
- DRUG Nicotine Replacement Patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2011-10-01 |
| Est. Completion | 2015-01-01 |
| Phase | Early Phase 1 |
What the finished NCT01434342 record still lists
NCT01434342 is an interventional study that assigns participants to a tested intervention. The registered 146 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (175% higher).
The record links to 0 conditions, and to 1 intervention - of which Nicotine Replacement Patch is the first listed.
NCT01434342 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01434342 about?
NCT01434342 is a clinical study titled "Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients". RATIONALE: Continued smoking after a cancer diagnosis has important health consequences beyond the risks associated with smoking in the general population. Smoking reduces the efficacy of cancer treatments including surgery, radiation and chemotherapy. Despite the negative consequences, it is estima...
What is the current status of trial NCT01434342?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 146 participants. The study started on 2011-10-01. Estimated completion is 2015-01-01.
What interventions are being tested in trial NCT01434342?
The interventions under investigation include: Nicotine Replacement Patch (DRUG).
Who is sponsoring clinical trial NCT01434342?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01434342's enrollment target sits among peer trials
146 108th of 2000 higher than 1,893 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03490929 · 146 participants · Phase 4
CEUS for Blunt Abdominal Trauma in Children
- NCT04755062 · 146 participants · NA
A Culturally-relevant Micronutrient-dense Plant-rich (mNDPR) Dietary Intervention for Native Americans
- NCT04867954 · 146 participants
Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis
- NCT05051618 · 146 participants · NA
Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI